105 related articles for article (PubMed ID: 21227702)
1. Synthesis and serotonin transporter activity of 1,3-bis(aryl)-2-nitro-1-propenes as a new class of anticancer agents.
McNamara YM; Cloonan SM; Knox AJ; Keating JJ; Butler SG; Peters GH; Meegan MJ; Williams DC
Bioorg Med Chem; 2011 Feb; 19(3):1328-48. PubMed ID: 21227702
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, Antiproliferative and Pro-Apoptotic Effects of Nitrostyrenes and Related Compounds in Burkitt's Lymphoma.
Byrne AJ; Bright SA; Fayne D; McKeown JP; McCabe T; Twamley B; Williams C; Meegan MJ
Med Chem; 2018 Feb; 14(2):181-199. PubMed ID: 28969575
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and serotonin transporter activity of sulphur-substituted alpha-alkyl phenethylamines as a new class of anticancer agents.
Cloonan SM; Keating JJ; Butler SG; Knox AJ; Jørgensen AM; Peters GH; Rai D; Corrigan D; Lloyd DG; Williams DC; Meegan MJ
Eur J Med Chem; 2009 Dec; 44(12):4862-88. PubMed ID: 19717215
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and preliminary evaluation of selected 2-aryl-5(6)-nitro- 1H-benzimidazole derivatives as potential anticancer agents.
Romero-Castro A; León-Rivera I; Avila-Rojas LC; Navarrete-Vázquez G; Nieto-Rodríguez A
Arch Pharm Res; 2011 Feb; 34(2):181-9. PubMed ID: 21380799
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and antiproliferative action of a novel series of maprotiline analogues.
McNamara YM; Bright SA; Byrne AJ; Cloonan SM; McCabe T; Williams DC; Meegan MJ
Eur J Med Chem; 2014 Jan; 71():333-53. PubMed ID: 24333581
[TBL] [Abstract][Full Text] [Related]
6. The serotonin transporter (SLC6A4) is present in B-cell clones of diverse malignant origin: probing a potential anti-tumor target for psychotropics.
Meredith EJ; Holder MJ; Chamba A; Challa A; Drake-Lee A; Bunce CM; Drayson MT; Pilkington G; Blakely RD; Dyer MJ; Barnes NM; Gordon J
FASEB J; 2005 Jul; 19(9):1187-9. PubMed ID: 15870169
[TBL] [Abstract][Full Text] [Related]
7. Flavopiridol induces apoptosis and caspase-3 activation of a newly characterized Burkitt's lymphoma cell line containing mutant p53 genes.
Rapoport AP; Simons-Evelyn M; Chen T; Sidell R; Luhowskyj S; Rosell K; Obrig T; Hicks D; Hinkle PM; Nahm M; Insel RA; Abboud CN
Blood Cells Mol Dis; 2001; 27(3):610-24. PubMed ID: 11482875
[TBL] [Abstract][Full Text] [Related]
8. 7-b, a novel amonafide analogue, cause growth inhibition and apoptosis in Raji cells via a ROS-mediated mitochondrial pathway.
Lin B; Chen Z; Xu Y; Zhang H; Liu J; Qian X
Leuk Res; 2011 May; 35(5):646-56. PubMed ID: 21310484
[TBL] [Abstract][Full Text] [Related]
9. Discovery of 4-aryl-4H-chromenes as a new series of apoptosis inducers using a cell- and caspase-based high-throughput screening assay. 1. Structure-activity relationships of the 4-aryl group.
Kemnitzer W; Drewe J; Jiang S; Zhang H; Wang Y; Zhao J; Jia S; Herich J; Labreque D; Storer R; Meerovitch K; Bouffard D; Rej R; Denis R; Blais C; Lamothe S; Attardo G; Gourdeau H; Tseng B; Kasibhatla S; Cai SX
J Med Chem; 2004 Dec; 47(25):6299-310. PubMed ID: 15566300
[TBL] [Abstract][Full Text] [Related]
10. New cytotoxic rosamine derivatives selectively accumulate in the mitochondria of cancer cells.
Lim SH; Wu L; Burgess K; Lee HB
Anticancer Drugs; 2009 Jul; 20(6):461-8. PubMed ID: 19387338
[TBL] [Abstract][Full Text] [Related]
11. Quinazolinone linked pyrrolo[2,1-c][1,4]benzodiazepine (PBD) conjugates: Design, synthesis and biological evaluation as potential anticancer agents.
Kamal A; Vijaya Bharathi E; Janaki Ramaiah M; Dastagiri D; Surendranadha Reddy J; Viswanath A; Sultana F; Pushpavalli SN; Pal-Bhadra M; Srivastava HK; Narahari Sastry G; Juvekar A; Sen S; Zingde S
Bioorg Med Chem; 2010 Jan; 18(2):526-42. PubMed ID: 20031423
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and antiproliferative activity of novel aminosubstituted benzothiopyranoisoindoles.
Christodoulou A; Kostakis IK; Kourafalos V; Pouli N; Marakos P; Trougakos IP; Tsitsilonis OE
Bioorg Med Chem Lett; 2011 May; 21(10):3110-2. PubMed ID: 21444205
[TBL] [Abstract][Full Text] [Related]
13. Design and synthesis of novel amino-substituted xanthenones and benzo[b]xanthenones: evaluation of their antiproliferative activity and their ability to overcome multidrug resistance toward MES-SA/D x 5 cells.
Kostakis IK; Pouli N; Marakos P; Skaltsounis AL; Pratsinis H; Kletsas D
Bioorg Med Chem; 2006 May; 14(9):2910-34. PubMed ID: 16376546
[TBL] [Abstract][Full Text] [Related]
14. Pyrrolo[1,5]benzoxa(thia)zepines as a new class of potent apoptotic agents. Biological studies and identification of an intracellular location of their drug target.
Mc Gee MM; Gemma S; Butini S; Ramunno A; Zisterer DM; Fattorusso C; Catalanotti B; Kukreja G; Fiorini I; Pisano C; Cucco C; Novellino E; Nacci V; Williams DC; Campiani G
J Med Chem; 2005 Jun; 48(13):4367-77. PubMed ID: 15974589
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, and biological evaluation of alcyopterosin A and illudalane derivatives as anticancer agents.
Finkielsztein LM; Bruno AM; Renou SG; Moltrasio Iglesias GY
Bioorg Med Chem; 2006 Mar; 14(6):1863-70. PubMed ID: 16321541
[TBL] [Abstract][Full Text] [Related]
16. The Morita-Baylis-Hillman adducts of beta-aryl nitroethylenes with other activated alkenes: synthesis and anticancer activity studies.
Dadwal M; Mohan R; Panda D; Mobin SM; Namboothiri IN
Chem Commun (Camb); 2006 Jan; (3):338-40. PubMed ID: 16391753
[TBL] [Abstract][Full Text] [Related]
17. Potential mechanism of resistance to TRAIL-induced apoptosis in Burkitt's lymphoma.
Tafuku S; Matsuda T; Kawakami H; Tomita M; Yagita H; Mori N
Eur J Haematol; 2006 Jan; 76(1):64-74. PubMed ID: 16343273
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, in vitro cytotoxicity and apoptosis inducing study of 2-aryl-3-nitro-2H-chromene derivatives as potent anti-breast cancer agents.
Rahmani-Nezhad S; Safavi M; Pordeli M; Ardestani SK; Khosravani L; Pourshojaei Y; Mahdavi M; Emami S; Foroumadi A; Shafiee A
Eur J Med Chem; 2014 Oct; 86():562-9. PubMed ID: 25216378
[TBL] [Abstract][Full Text] [Related]
19. Basic N-interlinked imipramines show apoptotic activity against malignant cells including Burkitt's lymphoma.
Bright SA; Brinkø A; Larsen MT; Sinning S; Williams DC; Jensen HH
Bioorg Med Chem Lett; 2013 Mar; 23(5):1220-4. PubMed ID: 23385211
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of new symmetrical derivatives as cytotoxic agents and apoptosis inducers.
Sanmartín C; Echeverría M; Mendívil B; Cordeu L; Cubedo E; García-Foncillas J; Font M; Palop JA
Bioorg Med Chem; 2005 Mar; 13(6):2031-44. PubMed ID: 15727857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
